UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
[X] |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2003
OR
[ ] |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission file number: 333-101188
WH INTERMEDIATE HOLDINGS LTD.
Cayman Islands (State or other jurisdiction of incorporation or organization) |
98-0379050 (I.R.S. Employer Identification No.) |
P.O. Box 309GT
Ungland House, South Church Street
Grand Cayman, Cayman Island
(Address of principal executive offices) (Zip code)
(310) 410-9600*
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X]
Number of shares of registrants common stock outstanding as of March 31, 2003 was 1.
* C/O Principal Financial Officer of Herbalife International, Inc.
WH INTERMEDIATE HOLDINGS Ltd.
Index to Financial Statements and Exhibits
Filed with the Quarterly Report of the Company on Form 10-Q
For the First Quarter Period ended March 31, 2003
Page No. | ||||||||
PART I. FINANCIAL INFORMATION | ||||||||
Item 1.
|
Financial Statements: | |||||||
Consolidated Balance Sheets | 2 - 3 | |||||||
Consolidated Statements of Income | 4 | |||||||
Consolidated Statements of Cash Flows | 5 | |||||||
Notes to Consolidated Financial Statements | 6 11 | |||||||
Item 2. |
Managements Discussion and Analysis of Financial Condition and Results of Operations | 11 - 15 | ||||||
Item 3. |
Quantitative and Qualitative Disclosures About Market Risks | 15 17 | ||||||
Item 4. |
Controls and Procedures | 17 | ||||||
PART II. OTHER INFORMATION | ||||||||
Item 1. |
Legal Proceedings | 17 | ||||||
Item 2. |
Changes in Securities and Use of Proceeds | 17 | ||||||
Item 3. |
Defaults Upon Senior Securities | 17 | ||||||
Item 4. |
Submission of Matters to a Vote of Security Holders | 17 | ||||||
Item 5. |
Other Information | 17 | ||||||
Item 6. |
Exhibits and Reports on Form 8-K | 18 20 | ||||||
Signature and Certification |
21 23 |
1
PART I. FINANCIAL INFORMATION
Item 1. FINANCIAL STATEMENTS
WH INTERMEDIATE HOLDINGS LTD.
CONSOLIDATED BALANCE SHEETS
(Unaudited)
ASSETS
March 31, | December 31, | ||||||||
2003 | 2002 | ||||||||
CURRENT ASSETS: |
|||||||||
Cash and cash equivalents |
$ | 70,103,000 | $ | 64,201,000 | |||||
Marketable securities |
1,268,000 | 1,272,000 | |||||||
Receivables, including related party receivables of
$1,278,000 (2003) and $1,100,000 (2002) |
34,411,000 | 29,677,000 | |||||||
Inventories |
56,249,000 | 56,868,000 | |||||||
Prepaid expenses and other current assets |
12,841,000 | 16,075,000 | |||||||
Deferred income taxes |
27,113,000 | 26,708,000 | |||||||
Total current assets |
201,985,000 | 194,801,000 | |||||||
Property, at cost, net of accumulated depreciation and
amortization of $13,104,000 (2003) and $7,675,000 (2002) |
43,412,000 | 46,112,000 | |||||||
Deferred compensation plan assets |
20,617,000 | 31,922,000 | |||||||
Other assets |
5,239,000 | 5,327,000 | |||||||
Deferred financing costs, net of accumulated amortization
of $5,304,000 (2003) and $3,446,000 (2002) |
36,453,000 | 38,310,000 | |||||||
Marketing Franchise |
180,000,000 | 180,000,000 | |||||||
Trademark and Tradename |
130,000,000 | 130,000,000 | |||||||
Product Certification and other intangible assets, net
of accumulated amortization of $2,467,000 (2003) and
$1,542,000 (2002) |
4,933,000 | 5,858,000 | |||||||
Goodwill |
211,063,000 | 211,063,000 | |||||||
TOTAL |
$ | 833,702,000 | $ | 843,393,000 | |||||
See the accompanying notes to consolidated financial statements
2
WH INTERMEDIATE HOLDINGS LTD.
CONSOLIDATED BALANCE SHEETS
(Unaudited)
LIABILITIES AND STOCKHOLDERS EQUITY
March 31, | December 31, | ||||||||
2003 | 2002 | ||||||||
CURRENT LIABILITIES: |
|||||||||
Accounts payable |
$ | 18,779,000 | $ | 21,799,000 | |||||
Royalty overrides |
58,568,000 | 69,062,000 | |||||||
Accrued compensation |
16,581,000 | 22,443,000 | |||||||
Accrued expenses |
39,365,000 | 47,342,000 | |||||||
Current portion of long-term debt |
18,755,000 | 19,160,000 | |||||||
Advance sales deposits |
9,495,000 | 6,307,000 | |||||||
Income taxes payable |
16,880,000 | 11,782,000 | |||||||
Total current liabilities |
178,423,000 | 197,895,000 | |||||||
NON-CURRENT LIABILITIES: |
|||||||||
Long-term debt, net of current portion |
284,626,000 | 284,839,000 | |||||||
Deferred compensation |
23,718,000 | 32,082,000 | |||||||
Deferred income taxes |
110,498,000 | 110,707,000 | |||||||
Other non-current liabilities |
2,482,000 | 2,524,000 | |||||||
Total liabilities |
599,747,000 | 628,047,000 | |||||||
STOCKHOLDERS EQUITY: |
|||||||||
Common Stock, $1.00 par value, 50,000 shares authorized,
1 share issued and outstanding |
| | |||||||
Paid-in-capital in excess of par value |
192,776,000 | 192,776,000 | |||||||
Retained earnings |
41,271,000 | 22,709,000 | |||||||
Accumulated other comprehensive loss |
(92,000 | ) | (139,000 | ) | |||||
Total stockholders equity |
233,955,000 | 215,346,000 | |||||||
TOTAL |
$ | 833,702,000 | $ | 843,393,000 | |||||
See the accompanying notes to consolidated financial statements
3
WH INTERMEDIATE HOLDINGS LTD.
CONSOLIDATED STATEMENTS OF INCOME
Three Months Ended | |||||||||
March 31, 2003 | March 31, 2002 | ||||||||
(Successor) | (Predecessor) | ||||||||
Retail sales |
$ | 457,073,000 | $ | 432,741,000 | |||||
Distributor allowances on product purchases |
(216,675,000 | ) | (203,510,000 | ) | |||||
Handling and freight income |
39,641,000 | 36,563,000 | |||||||
Net sales |
280,039,000 | 265,794,000 | |||||||
Cost of sales |
56,960,000 | 57,072,000 | |||||||
Gross Profit |
223,079,000 | 208,722,000 | |||||||
Royalty overrides |
99,511,000 | 94,726,000 | |||||||
Marketing, distribution and administrative expenses |
84,297,000 | 81,149,000 | |||||||
Income from operations before interest, income taxes and minority interest |
39,271,000 | 32,847,000 | |||||||
Interest expense (income) net |
8,336,000 | (575,000 | ) | ||||||
Income before income taxes and minority interest |
30,935,000 | 33,422,000 | |||||||
Income taxes |
12,374,000 | 13,369,000 | |||||||
Income before minority interest |
18,561,000 | 20,053,000 | |||||||
Minority interest |
| 140,000 | |||||||
NET INCOME |
$ | 18,561,000 | $ | 19,913,000 | |||||
See the accompanying notes to consolidated financial statements
4
WH INTERMEDIATE HOLDINGS LTD.
CONSOLIDATED STATEMENTS OF CASH FLOWS
Three Months Ended | ||||||||||||
March 31, 2003 | March 31, 2002 | |||||||||||
(Successor) | (Predecessor) | |||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES |
||||||||||||
Net income |
$ | 18,561,000 | $ | 19,913,000 | ||||||||
Adjustments to reconcile net income to net cash
(used in) provided by operating activities: |
||||||||||||
Depreciation and amortization |
6,389,000 | 4,909,000 | ||||||||||
Amortization of deferred financing costs |
1,858,000 | | ||||||||||
Deferred income taxes |
(614,000 | ) | 2,618,000 | |||||||||
Unrealized foreign exchange loss |
1,804,000 | 1,157,000 | ||||||||||
Minority interest in earnings |
| 140,000 | ||||||||||
Other |
102,000 | 645,000 | ||||||||||
Changes in operating assets and liabilities: |
||||||||||||
Receivables |
(4,698,000 | ) | 1,504,000 | |||||||||
Inventories |
557,000 | 9,329,000 | ||||||||||
Prepaid expenses and other current assets |
2,577,000 | (1,586,000 | ) | |||||||||
Accounts payable |
(3,158,000 | ) | (125,000 | ) | ||||||||
Royalty overrides |
(11,101,000 | ) | (6,893,000 | ) | ||||||||
Accrued expenses and accrued compensation |
(14,229,000 | ) | (2,981,000 | ) | ||||||||
Advance sales deposits |
3,067,000 | 564,000 | ||||||||||
Income taxes payable |
5,231,000 | 5,257,000 | ||||||||||
Deferred compensation liability |
(8,363,000 | ) | (3,057,000 | ) | ||||||||
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES |
(2,017,000 | ) | 31,394,000 | |||||||||
CASH FLOWS FROM INVESTING ACTIVITIES |
||||||||||||
Purchases of property |
(1,349,000 | ) | (2,288,000 | ) | ||||||||
Proceeds from sale of property |
1,000 | 115,000 | ||||||||||
Changes in marketable securities, net |
6,000 | 104,000 | ||||||||||
Changes in other assets |
(76,000 | ) | 59,000 | |||||||||
Deferred compensation plan assets |
11,304,000 | 49,000 | ||||||||||
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES |
9,886,000 | (1,961,000 | ) | |||||||||
CASH FLOWS FROM FINANCING ACTIVITIES |
||||||||||||
Dividends paid |
| (4,806,000 | ) | |||||||||
Additions to long-term debt |
295,000 | 29,000 | ||||||||||
Principal payments on long-term debt |
(2,354,000 | ) | (1,273,000 | ) | ||||||||
Exercise of stock options |
| 6,934,000 | ||||||||||
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES |
(2,059,000 | ) | 884,000 | |||||||||
EFFECT OF EXCHANGE RATE CHANGES ON CASH |
92,000 | (1,761,000 | ) | |||||||||
NET CHANGE IN CASH AND CASH EQUIVALENTS |
5,902,000 | 28,556,000 | ||||||||||
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD |
64,201,000 | 179,237,000 | ||||||||||
CASH AND CASH EQUIVALENTS, END OF PERIOD |
$ | 70,103,000 | $ | 207,793,000 | ||||||||
NON-CASH ACTIVITIES: |
||||||||||||
Acquisitions of property from capital leases |
$ | 1,371,000 | $ | 1,432,000 | ||||||||
See the accompanying notes to consolidated financial statements
5
WH INTERMEDIATE HOLDINGS LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. | ORGANIZATION |
WH Intermediate Holdings Ltd., a Cayman Islands company (the Parent), and its direct and indirect wholly owned subsidiaries, WH Luxembourg Holdings S.à.R.L., a Luxembourg unipersonal limited liability company (Lux Holdings), WH Luxembourg Intermediate Holdings S.à.R.L., a Luxembourg unipersonal limited liability company (Lux Intermediate), Herbalife International Luxembourg S.à.R.L. (Herbalife Lux), formerly known as WH Luxembourg CM S.à.R.L., a Luxembourg unipersonal limited liability company, and WH Acquisition Corp., a Nevada corporation (WH Acquisition), were formed on behalf of Whitney & Co., LLC (Whitney) and Golden Gate Private Equity, Inc. (Golden Gate), in order to acquire Herbalife International, Inc., a Nevada corporation, and its subsidiaries (Herbalife or Predecessor). The Parent and its subsidiaries are referred to collectively herein as the Company.
2. | BASIS OF PRESENTATION |
The unaudited interim financial information of the Parent and its subsidiaries (the Successor) and of Herbalife and its subsidiaries have been prepared in accordance with Article 10 of the Securities and Exchange Commissions Regulation S-X. The Successor financial statements as of March 31, 2003 and for the three months ended March 31, 2003 include the Parent, and all of its direct and indirect subsidiaries, including Herbalife from the date of the merger. In the opinion of management, the accompanying interim financial information contains all adjustments, consisting of normal recurring adjustments, necessary to present fairly the Companys financial statements as of March 31, 2003 and for the three-month periods ended March 31, 2003 and 2002.
As a result of the merger and related financing transactions results prior to the merger are not comparable with those subsequent to the merger.
Reclassifications
Certain reclassifications were made to the prior year financial statements to conform to the current year presentation.
New Accounting Pronouncements
In April 2002, the Financial Accounting Standards Board (FASB) issued SFAS No. 145, Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections. SFAS No. 145 rescinds or amends, effective immediately upon adoption, several other existing authoritative pronouncements to make various technical corrections, clarify meanings, or describe their applicability under changed conditions. In July 2002, the FASB issued SFAS No. 146, Accounting for Costs Associated with Exit or Disposal Activities. The standard requires companies to recognize costs associated with exit or disposal activities when they are incurred rather than at the date of a commitment to an exit or disposal plan. SFAS No. 146 is to be applied prospectively to exit or disposal activities initiated after December 31, 2002. In November 2002, the FASB issued FASB Interpretation No. (FIN) 45, Guarantors Accounting and Disclosure Requirements for Guarantees, including Indirect Guarantees of Indebtedness of Others. This Interpretation elaborates on the disclosures to be made by a guarantor in its interim and annual financial statements and its obligations under certain guarantees that it has issued. It also clarifies that a guarantor is required to recognize, at the inception of a guarantee, a liability for the fair value of the obligation undertaken in issuing the guarantee. The initial recognition and initial measurement provisions of this Interpretation are applicable on a prospective basis to guarantees issued or modified after December 31, 2002. The disclosure requirements in this Interpretation are effective for financial statements of interim or annual periods ending after December 15, 2002. As of January 1, 2003, the adoption of these pronouncements had no material impact on the Companys financial statements.
In January 2003, the FASB issued Interpretation No. (FIN) 46, Consolidation of Variable Interest Entities, an interpretation of ARB No. 51. FIN 46 requires that Variable Interest Entities be consolidated by an entity (Company) if the Company is subject to a majority of the risk of loss from the Variable Interest Entitys activities or is entitled to receive a majority of the variable entitys residual returns or both. FIN 46 requires disclosures about variable interest entities that Companies are not required to consolidate but in which a Company has a significant variable interest. The Interpretation applies immediately to variable interest entities created after January 31, 2003, and to variable interest entities in which an enterprise obtains an interest after that date. It applies in the first fiscal year or interim period beginning after June 15, 2003, to variable interest entities in which an enterprise holds a variable interest that it acquired before February 2, 2003. The Interpretation applies to public enterprises as of the beginning of the applicable interim or annual period. The Company is currently evaluating the potential impact of the adoption of FIN 46 on its financial statements.
6
3. | TRANSACTIONS WITH RELATED PARTIES |
The Company has entered into agreements with Whitney and Golden Gate to pay monitoring fees for their services and other fees and expenses. Under the monitoring fee agreements, the Company is obligated to pay an annual amount of up to $5.0 million, but not less than $2.5 million for an initial period of ten years subject to the provisions in the Credit Agreement as amended. For the three months ended March 31, 2003, the Company expensed monitoring fees in the amount of $1.3 million and other expenses of $1.6 million. Also, in connection with the Senior Credit Facility discussed in Note 4, Whitney Private Debt Fund, L.P. loaned $5.0 million of the $180 million term loan to Herbalife.
Frank P. Morse and Robert A. Sandler, two former senior executives of the Company, are minority shareholders in B.L.I. Holdings, Inc., a holding Company for two of the Companys suppliers of personal care products. Total purchases from B.L.I. Holdings, Inc. and its subsidiaries was $494,000 for the three months ended March 31, 2002.
4. LONG-TERM DEBT
Long-term debt consisted of the following:
March 31, | December 31, | |||||||
2003 | 2002 | |||||||
Senior Subordinated Notes |
$ | 163,059,000 | $ | 162,992,000 | ||||
Borrowing under Senior Credit Facility |
135,000,000 | 135,000,000 | ||||||
Capitalized leases |
3,175,000 | 3,252,000 | ||||||
Other debt |
2,147,000 | 2,755,000 | ||||||
303,381,000 | 303,999,000 | |||||||
Less: current portion |
18,755,000 | 19,160,000 | ||||||
$ | 284,626,000 | $ | 284,839,000 | |||||
5. | CONTINGENCIES |
The Company is from time to time engaged in routine litigation. The Company regularly reviews all pending litigation matters in which it is involved and establishes reserves deemed appropriate by management for these litigation matters. However, some of these matters are material and an adverse outcome in these matters could have a material impact on the Companys financial condition and operating results.
The Company and certain of its distributors have been named as defendants in a purported class action lawsuit filed in the U.S. District Court for the Central District of California (Jacobs v. Herbalife International, Inc., et al.). The lawsuit was filed on February 19, 2002. The complaint was dismissed with leave to amend and an amended complaint was received on January 2, 2003. The amended complaint was dismissed with leave to amend, although the RICO causes of action were dismissed with prejudice. A second amended complaint was received on May 2, 2003. The second amended complaint alleges that specified marketing plans employed by the distributor defendants are illegal, attempts to challenge the legality of Herbalifes marketing system, and seeks to state causes of action under federal securities laws and various other laws. The Company believes that it has meritorious defenses to the allegations contained in the lawsuit. However, an adverse result in this litigation could have a material adverse effect on the Companys financial condition and operating results.
Whitney, one of the two equity sponsors (Equity Sponsors), has been sued in San Francisco by Rosemont Associates and Joseph Urso for $20 million in a suit alleging breach of contract, breach of covenants of good faith and fair dealing, quantum meruit and other causes of action arising out of the sale of Herbalife to Whitney and others. In connection with the merger, WH Holdings and the Company agreed to indemnify the Equity Sponsors for losses and claims resulting from, arising out of or any way related to the Merger, including existing litigation. Whitney believes it has meritorious defenses to the suit and is vigorously contesting it. However, an adverse result in this litigation could have a material adverse effect on the Companys financial condition and operating results.
As a marketer of dietary and nutritional supplements and other products that are ingested by consumers or applied to their bodies, the Company has been and is currently subjected to various product liability claims. Although the effects of these claims to date have not been material to the Company, it is possible that current and future product liability claims could have a material adverse impact on the Companys financial condition and operating results given the higher level of self insurance the Company has accepted. The Company currently maintains product liability insurance with a deductible of $7.5 million.
7
Certain of the Companys subsidiaries have been subject to tax audits by governmental authorities in their respective countries. In certain of these tax audits, governmental authorities are proposing that significant amounts of additional taxes and related interest and penalties are due. The Company and its tax advisors believe that there are substantial defenses to the allegations that additional taxes are owing, and the Company is vigorously contesting the additional proposed taxes and related charges. These matters may take several years to resolve, and the Company cannot be sure of their ultimate resolution. However, an adverse outcome in these matters could have a material adverse impact on the Companys financial condition and operating results.
6. | COMPREHENSIVE INCOME |
Comprehensive income is summarized as follows:
Three Months Ended | ||||||||
March 31, 2003 | March 31, 2002 | |||||||
Net income |
$ | 18,561,000 | $ | 19,913,000 | ||||
Net change on derivative instruments |
(475,000 | ) | (655,000 | ) | ||||
Foreign currency translation adjustment |
520,000 | (1,155,000 | ) | |||||
Unrealized
gain (loss) on marketable securities |
2,000 | (5,000 | ) | |||||
Comprehensive income (loss) |
$ | 18,608,000 | $ | 18,098,000 | ||||
The net change on derivative instruments represents the fair value changes caused by marking to market these instruments on March 31, 2003. Foreign currency translation adjustment measures the impact of converting primarily foreign currency assets and liabilities into US dollars. Gains/(losses) on marketable securities reflects the change in fair value of securities classified as available for sale.
7. | SEGMENT INFORMATION |
The Company is a network marketing company that sells a wide range of weight management products, nutritional supplements and personal care products within one industry segment as defined under SFAS No. 131, Disclosures about Segments of an Enterprise and Related Information. The Companys products are primarily manufactured by third party providers and then sold to independent distributors who sell Herbalife products to retail consumers or other distributors.
The Company has operations throughout the world and is organized and managed by geographic area. In the first quarter of 2003, the Company elected to aggregate its operating segments into one reporting segment, as management believes that the operating segments have similar operating characteristics and similar long term operating performance. In making this determination, management believes that the operating segments are similar in the nature of the products sold, the product acquisition process, the types of customers sold to, the methods used to distribute the products, and the nature of the regulatory environment.
Three Months Ended | |||||||||
March 31, 2003 | March 31, 2002 | ||||||||
(Dollars in millions) | |||||||||
Retail Sales by Geographic Region: |
|||||||||
The Americas |
$ | 161.6 | $ | 175.7 | |||||
Europe |
173.3 | 123.2 | |||||||
Asia/Pacific Rim |
122.2 | 133.8 | |||||||
$ | 457.1 | $ | 432.7 | ||||||
Retail Sales by Product Line: |
|||||||||
Nutritional Supplements |
$ | 206.7 | $ | 196.6 | |||||
Weight Management Products |
200.7 | 184.9 | |||||||
Personal Care Products |
43.9 | 45.4 | |||||||
Literature, Promotional and Other |
5.8 | 5.8 | |||||||
Total |
$ | 457.1 | $ | 432.7 | |||||
Additional information as to the Companys operations in different geographic areas:
Retail Sales
Retail sales from the Companys operations in Japan totaled $60.5 million and $65.5 million for the three-months ended March 31, 2003 and 2002, respectively. Retail sales from the Companys operations in United States totaled $107.1 million and $128.6 million for the three-months ended March 31, 2003 and 2002, respectively.
8
Long-lived Assets
Long-lived assets in Japan totaled $57.6 million and $57.9 million as of March 31, 2003 and December 31, 2002, respectively. Long-lived assets in United States totaled $ 433.6 million and $436.4 million as of March 31, 2003 and December 31, 2002, respectively.
8. | DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES |
The Company designates certain derivatives as fair value hedges. For all qualifying and highly effective fair value hedges, the changes in the fair value of a derivative and the gain or loss on the hedged asset or liability relating to the risk being hedged are recorded currently in earnings. These amounts are recorded in marketing, distribution and administrative expenses and provide offsets to one another.
The Company designates certain derivatives as cash flow hedges. The Company engages in a foreign exchange hedging strategy for which the hedged transactions are forecasted foreign currency denominated intercompany transactions. The hedged risk is the variability of the foreign currency where the hedging strategy involves the purchase and sale of average rate options. For the outstanding cash flow hedges on foreign exchange exposures at March 31, 2003, the maximum length of time over which the Company is hedging these exposures is 6 months. The Company also engages in an interest rate hedging strategy for which the hedged transactions are forecasted interest payments on the variable rate term loan. The hedged risk is the variability of interest rate where the hedging strategy involves the purchase of interest rate caps. For all qualifying and highly effective cash flow hedges, the changes in the effective portion of the fair value of the derivative are recorded in other comprehensive income (OCI). At March 31, 2003, the net loss in OCI was $920,000. Substantially, all OCI amounts will be reclassified to earnings within 12 months.
9. | RESTRUCTURING RESERVE |
As of the date of the merger, the Company started to implement a plan to reduce costs of the business and recorded a severance and restructuring accrual as part of the cost of the merger. The accrued severance is for identified employees including executives, corporate functions and administrative support. There may be other employees identified for involuntary termination to complete the plan and, if so, an additional amount of severance will be accrued and goodwill will increase. Actions required by the plan of termination began immediately after consummation of the transaction and the period of time to complete the plan will not extend past 12 months after the merger date.
The following table summarizes the activity in the Companys restructuring accrual:
(in millions) | ||||
Balance at December 31, 2002 |
$ | 8.7 | ||
Payments made |
(5.3 | ) | ||
Balance at March 31, 2003 |
$ | 3.4 | ||
10. | SUPPLEMENTAL INFORMATION |
The consolidated financial statement data, as of March 31, 2003 and the three months ended March 31, 2003 has been aggregated by entities that guarantee the Senior Subordinated Notes (the Guarantors) and entities that do not guarantee the Senior Subordinated Notes (the Non-Guarantors). The Guarantors include the Parent, Lux Holdings, Lux Intermediate, Herbalife Lux (collectively, the Parent Guarantors) and Herbalifes operating subsidiaries in Brazil, Finland, Israel, Japan, Mexico, United Kingdom, U.S. (other than Herbalife Investment Co., LLC), Sweden, Taiwan and Thailand (collectively, the Subsidiary Guarantors). All other subsidiaries are Non-Guarantors.
The consolidated financial statements of the Predecessor for the three months ended March 31, 2002 include the accounts of Herbalife and its subsidiaries.
Consolidating condensed statements of income for the three months ended March 31, 2003 and March 31, 2002 are summarized as follows:
9
Quarter Ended March 31, 2003 | ||||||||||||||||||||||||
Herbalife | ||||||||||||||||||||||||
Parent | International, | Subsidiary | Total | |||||||||||||||||||||
Guarantors | Inc. | Guarantors | Non-Guarantors | Eliminations | Consolidated | |||||||||||||||||||
Net sales |
$ | | $ | | $ | 246.5 | $ | 60.4 | $ | (26.9 | ) | $ | 280.0 | |||||||||||
Cost of sales |
| | 55.0 | 28.7 | (26.7 | ) | 57.0 | |||||||||||||||||
Royalty overrides |
| | 63.1 | 36.4 | | 99.5 | ||||||||||||||||||
Marketing, distribution & administrative
expenses |
| 2.4 | 63.4 | 18.5 | | 84.3 | ||||||||||||||||||
Equity in Subsidiary (Income) loss |
(18.6 | ) | (24.3 | ) | (0.4 | ) | | 43.3 | | |||||||||||||||
Interest expense (income) net |
| 8.6 | (0.3 | ) | | | 8.3 | |||||||||||||||||
Intercompany charges |
| (2.2 | ) | 31.6 | (29.4 | ) | | | ||||||||||||||||
Income before income taxes and minority interest |
18.6 | 15.5 | 34.1 | 6.2 | (43.5 | ) | 30.9 | |||||||||||||||||
Income taxes |
| (3.1 | ) | 13.5 | 1.9 | | 12.3 | |||||||||||||||||
NET INCOME |
$ | 18.6 | $ | 18.6 | $ | 20.6 | $ | 4.3 | $ | (43.5 | ) | $ | 18.6 | |||||||||||
Quarter Ended March 31, 2002 | ||||||||||||||||||||
Herbalife | ||||||||||||||||||||
International, | Subsidiary | Total | ||||||||||||||||||
Inc. | Guarantors | Non-Guarantors | Eliminations | Consolidated | ||||||||||||||||
Net sales |
$ | | $ | 230.0 | $ | 55.9 | $ | (20.1 | ) | $ | 265.8 | |||||||||
Cost of sales |
| 53.1 | 24.5 | (20.5 | ) | 57.1 | ||||||||||||||
Royalty overrides |
| 63.5 | 31.2 | | 94.7 | |||||||||||||||
Marketing, distribution & administrative
expenses |
(0.1 | ) | 65.4 | 15.8 | | 81.1 | ||||||||||||||
Equity in Subsidiary (Income) loss |
(20.3 | ) | (0.1 | ) | | 20.4 | | |||||||||||||
Interest expense (income) net |
| (0.8 | ) | 0.3 | | (0.5 | ) | |||||||||||||
Intercompany charges |
(3.2 | ) | 22.5 | (19.3 | ) | | | |||||||||||||
Income before income taxes and minority interest |
23.6 | 26.4 | 3.4 | (20.0 | ) | 33.4 | ||||||||||||||
Income taxes |
3.7 | 7.9 | 1.8 | | 13.4 | |||||||||||||||
Income before minority interest |
19.9 | 18.5 | 1.6 | (20.0 | ) | 20.0 | ||||||||||||||
Minority interest |
| 0.1 | | | 0.1 | |||||||||||||||
NET INCOME |
$ | 19.9 | $ | 18.4 | $ | 1.6 | $ | (20.0 | ) | $ | 19.9 | |||||||||
Consolidating condensed balance sheet data as of March 31, 2003 and December 31, 2002 are summarized as follows:
March 31, 2003 (in millions) | |||||||||||||||||||||||||
Herbalife | |||||||||||||||||||||||||
Parent | International, | Subsidiary | Total | ||||||||||||||||||||||
Guarantors | Inc. | Guarantors | Non-Guarantors | Eliminations | Consolidated | ||||||||||||||||||||
Current Assets: |
|||||||||||||||||||||||||
Cash and marketable securities |
$ | | $ | 0.2 | $ | 36.1 | $ | 35.1 | $ | | $ | 71.4 | |||||||||||||
Receivables |
| 2.6 | 24.9 | 9.5 | (2.6 | ) | 34.4 | ||||||||||||||||||
Intercompany receivables |
(0.3 | ) | 207.6 | (129.2 | ) | (78.1 | ) | | | ||||||||||||||||
Inventories |
| | 45.2 | 15.8 | (4.8 | ) | 56.2 | ||||||||||||||||||
Other Current Assets |
| 0.2 | 35.2 | 4.6 | | 40.0 | |||||||||||||||||||
Total current assets |
(0.3 | ) | 210.6 | 12.2 | (13.1 | ) | (7.4 | ) | 202.0 | ||||||||||||||||
Property, net |
| | 35.3 | 8.1 | | 43.4 | |||||||||||||||||||
Other Non-Current Assets |
41.5 | 413.6 | 186.0 | 53.3 | (106.1 | ) | 588.3 | ||||||||||||||||||
TOTAL ASSETS |
$ | 41.2 | $ | 624.2 | $ | 233.5 | $ | 48.3 | $ | (113.5 | ) | $ | 833.7 | ||||||||||||
Current Liabilities: |
|||||||||||||||||||||||||
Accounts Payable |
$ | | $ | | $ | 15.3 | $ | 3.5 | $ | | $ | 18.8 | |||||||||||||
Royalties Overrides |
| | 36.5 | 22.1 | | 58.6 | |||||||||||||||||||
Accrued compensation and expenses |
| 4.7 | 37.9 | 14.2 | (0.9 | ) | 55.9 | ||||||||||||||||||
Other current liabilities |
| (7.5 | ) | 52.6 | 2.6 | (2.6 | ) | 45.1 | |||||||||||||||||
Total current liabilities |
| (2.8 | ) | 142.3 | 42.4 | (3.5 | ) | 178.4 | |||||||||||||||||
Non-Current Liabilities |
| 409.2 | 12.5 | (0.4 | ) | | 421.3 | ||||||||||||||||||
Stockholders Equity |
41.2 | 217.8 | 78.7 | 6.3 | (110.0 | ) | 234.0 | ||||||||||||||||||
TOTAL LIABILITIES &
STOCKHOLDERS EQUITY |
$ | 41.2 | $ | 624.2 | $ | 233.5 | $ | 48.3 | $ | (113.5 | ) | $ | 833.7 | ||||||||||||
10
December 31, 2002 (in millions) | |||||||||||||||||||||||||
Herbalife | |||||||||||||||||||||||||
Parent | International, | Subsidiary | Total | ||||||||||||||||||||||
Guarantors | Inc. | Guarantors | Non-Guarantors | Eliminations | Consolidated | ||||||||||||||||||||
Current Assets: |
|||||||||||||||||||||||||
Cash and marketable securities |
$ | | $ | 0.3 | $ | 39.6 | $ | 25.5 | $ | | $ | 65.4 | |||||||||||||
Receivables |
| | 24.0 | 5.7 | | 29.7 | |||||||||||||||||||
Intercompany receivables |
| 141.8 | (75.9 | ) | (65.9 | ) | | | |||||||||||||||||
Inventories |
| | 46.2 | 15.2 | (4.5 | ) | 56.9 | ||||||||||||||||||
Other Current Assets |
0.2 | 0.2 | 38.2 | 18.6 | (14.4 | ) | 42.8 | ||||||||||||||||||
Total current assets |
0.2 | 142.3 | 72.1 | (0.9 | ) | (18.9 | ) | 194.8 | |||||||||||||||||
Property, net |
| | 37.4 | 8.7 | | 46.1 | |||||||||||||||||||
Other non-current assets |
22.8 | 397.0 | 195.0 | 55.2 | (67.5 | ) | 602.5 | ||||||||||||||||||
TOTAL ASSETS |
$ | 23.0 | $ | 539.3 | $ | 304.5 | $ | 63.0 | $ | (86.4 | ) | $ | 843.4 | ||||||||||||
Current Liabilities: |
|||||||||||||||||||||||||
Accounts Payable |
$ | | $ | | $ | 16.9 | $ | 4.9 | $ | | $ | 21.8 | |||||||||||||
Royalties Overrides |
| | 46.5 | 22.6 | | 69.1 | |||||||||||||||||||
Accrued compensation and expenses |
| 12.1 | 42.7 | 15.0 | | 69.8 | |||||||||||||||||||
Other current liabilities |
0.2 | (3.8 | ) | 39.6 | 15.6 | (14.4 | ) | 37.2 | |||||||||||||||||
Total current liabilities |
0.2 | 8.3 | 145.7 | 58.1 | (14.4 | ) | 197.9 | ||||||||||||||||||
Non-current liabilities |
| 409.1 | 19.7 | 1.4 | | 430.2 | |||||||||||||||||||
Stockholders Equity |
22.8 | 121.9 | 139.1 | 3.5 | (72.0 | ) | 215.3 | ||||||||||||||||||
TOTAL LIABILITIES &
STOCKHOLDERS EQUITY |
$ | 23.0 | $ | 539.3 | $ | 304.5 | $ | 63.0 | $ | (86.4 | ) | $ | 843.4 | ||||||||||||
Consolidating condensed statement of cash flows data for the three months ended March 31, 2003 and March 31, 2002 is summarized as follows:
Quarter Ended March 31, 2003 | ||||||||||||||||||||||||
Herbalife | ||||||||||||||||||||||||
Parent | International, | Subsidiary | Non- | Total | ||||||||||||||||||||
Guarantors | Inc. | Guarantors | Guarantors | Eliminations | Consolidated | |||||||||||||||||||
Net cash provided by (used in) operating activities |
$ | 18.6 | $ | 19.6 | $ | (0.8 | ) | $ | 10.7 | $ | (50.1 | ) | $ | (2.0 | ) | |||||||||
Net cash provided by (used in) investing activities |
(18.6 | ) | (19.8 | ) | 3.0 | 0.3 | 45.0 | 9.9 | ||||||||||||||||
Net cash provided by (used in) financing activities |
| | (5.6 | ) | (1.6 | ) | 5.1 | (2.1 | ) | |||||||||||||||
Effect of exchange rate changes on cash |
| | (0.1 | ) | 0.2 | | 0.1 | |||||||||||||||||
Cash at beginning of period |
| 0.5 | 38.2 | 25.5 | | 64.2 | ||||||||||||||||||
Cash at end of period |
$ | | $ | 0.3 | $ | 34.7 | $ | 35.1 | $ | | $ | 70.1 | ||||||||||||
Quarter Ended March 31, 2002 | ||||||||||||||||||||
Herbalife | ||||||||||||||||||||
International, | Subsidiary | Non- | Total | |||||||||||||||||
Inc. | Guarantors | Guarantors | Eliminations | Consolidated | ||||||||||||||||
Net cash provided by (used in) operating activities |
$ | 12.0 | $ | 35.0 | $ | 10.4 | $ | (26.0 | ) | $ | 31.4 | |||||||||
Net cash provided by (used in) investing activities |
(16.3 | ) | (2.4 | ) | 2.6 | 14.1 | (2.0 | ) | ||||||||||||
Net cash provided by (used in) financing activities |
4.3 | (6.2 | ) | (9.0 | ) | 11.9 | 1.0 | |||||||||||||
Effect of exchange rate changes on cash |
| (1.3 | ) | (0.5 | ) | | (1.8 | ) | ||||||||||||
Cash at beginning of period |
0.2 | 145.3 | 33.7 | | 179.2 | |||||||||||||||
Cash at end of period |
$ | 0.2 | $ | 170.4 | $ | 37.2 | $ | | $ | 207.8 | ||||||||||
Item 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
FORWARD LOOKING STATEMENTS
This document contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act). All statements other than statements of historical fact are forward-looking statements for purposes of federal and state securities laws, including any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operation; any statements concerning proposed new services of developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Forward-looking statements may include the words may, will, estimate, intend, continue, believe, expect or anticipate and other similar words.
Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, such as those disclosed in this document. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in forward-looking statements include, among others, the following: our relationships with our distributors; regulatory matters governing our products and network marketing system; adverse publicity associated with our products or network marketing organization; uncertainties relating to the application of transfer pricing and similar
11
tax regulations; taxation relating to distributors; product liability claims; our reliance on outside manufacturers and suppliers; risks associated with operating internationally, including foreign regulations, foreign exchange risks, trade restrictions, and political, economic and social instability; terrorist attacks and acts of war; concentration of retail sales in a small number of countries; risks associated with one product constituting a significant portion of retail sales; dependence on increased penetration of existing markets; the competitive nature of our business; our substantial indebtedness; and our ability to generate sufficient cash.
Recent Developments
WH Intermediate Holdings Ltd., a Cayman Islands company (the Parent), and its direct and indirect wholly owned subsidiaries, WH Luxembourg Holdings S.à.R.L., a Luxembourg unipersonal limited liability company (Lux Holdings), WH Luxembourg Intermediate Holdings S.à.R.L., a Luxembourg unipersonal limited liability company (Lux Intermediate), Herbalife International Luxembourg S.à.R.L. (Herbalife Lux), formerly known as WH Luxembourg CM S.à.R.L., a Luxembourg unipersonal limited liability company, and WH Acquisition Corp., a Nevada corporation (WH Acquisition), were formed on behalf of Whitney & Co., LLC (Whitney) and Golden Gate Private Equity, Inc. (Golden Gate), in order to acquire Herbalife International, Inc., a Nevada corporation, and its subsidiaries (Herbalife or Predecessor). The Parent and its subsidiaries, including Herbalife, are referred to collectively herein as the Company.
On April 3, 2003, the Company announced the appointment of Mr. Michael O. Johnson as Chief Executive Officer and director. The Company has entered into an executive employment agreement (the Employment Agreement) with Mr. Johnson effective as of April 3, 2003. For his services, Mr. Johnson is entitled to receive an annual salary of $850,000. Under the terms of the Employment Agreement, in addition to his salary, Mr. Johnson shall be entitled to participate in or receive benefits under each benefit plan or arrangement made available by the Company to its senior executives on terms no less favorable than those generally applicable to senior executives of the Company.
In addition, Mr. Johnson has been granted stock options under the WH Holdings (Cayman Islands) Ltd. Option Plan to purchase an aggregate of 5,911,845 shares of WH Holdings (Cayman Islands) Ltd. common stock at exercise prices as follows: 1,182,369 shares at $0.44 per share, 1,182,369 shares at $1.76 per share, 1,182,369 shares at $5.28 per share, 1,182,369 shares at $8.80 per share, and 1,182,369 shares at $12.32 per share. The options vest under a schedule over time through June 30, 2008. The options expire 10 years after the date of grant.
In the event of any Change of Control (as defined in the Plan), 50% of the shares granted pursuant to the options (pro rata according to the number of shares exercisable at the relevant exercise prices specified above for each of the individual tranches) will become immediately vested and exercisable. If, following any Change of Control, all or any portion of the options remain outstanding and Mr. Johnsons employment is terminated (other than by reason of Mr. Johnsons resignation without Good Reason or termination by the Company for Cause (as defined in the Employment Agreement)) at any time following such Change of Control, 100% of the shares granted pursuant to the options will immediately vest and become exercisable. In the event Mr. Johnsons employment is terminated by reason of Mr. Johnsons death or disability or during the 90 day period before any Change of Control, 100% of the shares granted pursuant to the options will immediately vest and become exercisable.
Critical Accounting Estimates
The Companys accounting policies are described in Note 2 to the Notes to Consolidated Financial Statements contained herein. The Company prepares its Consolidated Financial Statements in conformity with accounting principles generally accepted in the U.S., which require the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the year. Actual results could differ from those estimates. The Company considers the following policies to be most critical in understanding the judgments that are involved in preparing the Companys financial statements and the uncertainties that could impact its results of operations, financial condition and cash flows.
Allowances for product returns are provided at the time the product is shipped. This accrual is based upon historic trends and experience. If the actual product returns differ from past experience, changes in the allowances are made.
The Company writes down its inventory to provide for estimated obsolete or unsalable inventory based on assumptions about future demand for its products and market conditions. If future demand and market conditions are less favorable than managements assumptions, additional inventory write-downs could be required. Likewise, favorable future demand and market conditions could positively impact future operating results if written-off inventory is sold.
Contingencies are accounted for in accordance with SFAS No. 5, Accounting for Contingencies. SFAS No. 5 requires that the Company records an estimated loss from a loss contingency when information available prior to issuance of the Companys financial statements
12
indicates that it is probable that an asset has been impaired or a liability has been incurred at the date of the financial statements and the amount of the loss can be reasonably estimated. Accounting for contingencies such as legal and income tax matters requires the Company to use judgment. Many of these legal and tax contingencies can take years to be resolved. Generally, as the time period increases over which the uncertainties are resolved, the likelihood of changes to the estimate of the ultimate outcome increases. However, an adverse outcome in these matters could have a material impact on the Companys financial condition and operating results.
Deferred income tax assets have been established for net operating loss carryforwards of certain foreign subsidiaries and reduced by a valuation allowance. The net operating loss carryforwards expire in varying amounts over a future period of time. Realization of the income tax carryforwards is dependent on generating sufficient taxable income prior to expiration of the carryforwards. Although realization is not assured, management believes it is more likely than not that the net carrying value of the income tax carryforwards will be realized. The amount of the income tax carryforwards that is considered realizable, however, could change if estimates of future taxable income during the carryforward period are adjusted.
Results of Operations
The unaudited financial statements consist of financial information from Herbalife and its subsidiaries (the Predecessor) and the Parent and its subsidiaries (the Successor or the Company). For the purposes of managements discussion and analysis of financial condition and results of operations, the term Company refers to Herbalife International, Inc. and subsidiaries for periods through July 31, 2002 and to the Parent and subsidiaries for periods subsequent to July 31, 2002.
Throughout this report, retail sales represent the gross sales amounts reflected on the Companys invoices to its distributors. The Company does not receive the amount reported as retail sales, and the Company does not monitor the actual retail prices charged for its products. Net sales represent the actual purchase prices paid to the Company by its distributors, after giving effect to distributor discounts referred to as distributor allowances, which total approximately 50% of suggested retail sales prices and handling and freight income. Distributor allowances as a percentage of sales may vary by country depending upon regulatory restrictions that limit or otherwise restrict distributor allowances. The Company receives its net sales price in cash or through credit card payments upon receipt of orders from distributors. The Company utilizes importers in a limited number of markets and, under some circumstances, the Company extends credit terms to these importers. The Companys gross profit consists of net sales less cost of sales, consisting of the prices the Company pays to its manufacturers for products and costs related to product shipments, duties and tariffs, freight expenses relating to shipment of products to distributors and importers and similar expenses.
Royalty overrides consist of (i) royalty overrides and bonuses, which total approximately 15% and 7%, respectively, of the suggested retail sales prices of products earned by qualifying distributors on sales within their distributor organizations, (ii) the Presidents Team Bonus payable to some of the Companys most senior distributors in the aggregate amount of approximately an additional 1% of product retail sales, and (iii) other one-time incentive cash bonuses to qualifying distributors. These payments generally represent compensation to distributors for the development and retention of the distributor sales organizations. Because of local country regulatory constraints, the Company may be required to modify its typical distributor incentive plans as described above. Consequently, the total distributor discount percentage may vary over time. The Company also offers reduced distributor allowances and pays reduced royalty overrides with respect to certain products worldwide.
The Companys use of retail sales in reporting financial and operating data reflects the fundamental role of retail sales in its accounting systems, internal controls and operations, including the basis upon which distributor bonuses are paid. The retail sales price of the Companys products is reflected in distributor invoices as the price charged to distributors together with, in most cases, a deduction for the corresponding distributor allowance. The retail sales price is used by the Company to calculate, among other things, royalty overrides and volume points earned by distributors. Volume points are point values assigned to each of the Companys products that are equal in all countries and are used as supervisor qualification criteria. In addition, the Company relies upon retail sales data reflected in daily sales reports to monitor results of operations in each of its markets.
The significance of the Companys net sales is to reflect, generally, the prices actually received by the Company after deducting the basic distributor allowance and adding the handling and freight income. Accordingly, factors that affect retail sales generally have a corresponding and proportionate effect on net sales. To the extent the ratio of net sales to retail sales varies from period to period, these variances have resulted principally from sales of the Companys distributor kits and other educational and promotional materials, for which there are no distributor allowances, and increased sales of product on which the Company offers reduced distributor allowances.
Sales, related royalty overrides, and allowances for product returns are recorded when the merchandise is shipped in accordance with the Companys shipping terms. Advance sales deposits represent prepaid orders for which the Company has not shipped the merchandise.
13
The Companys results of operations for the periods described below are not necessarily indicative of results of operations for future periods, which depend upon numerous factors including the Companys ability in the future to attract and retain new distributors and to further penetrate its existing markets through the introduction of additional and new products into its markets.
Comparison of First Quarter 2003 to 2002. Retail sales for three months ended March 31, 2003 increased 5.6% to $457.1 million, as compared to retail sales of $432.7 million in the prior period. The increase was primarily due to the impact of a stronger euro and the 2003 first quarter-end did not fall on a weekend, as in 2002, resulting in more orders being completed and shipped within the month.
Retail Sales by Geographical Regions
Quarter Ended March 31 | |||||||||||||||||
% Change in | |||||||||||||||||
2003 | 2002 | % Change | Local Currency | ||||||||||||||
(Dollars in millions) | |||||||||||||||||
The Americas |
$ | 161.6 | $ | 175.7 | (8.0 | %) | (1.0 | %) | |||||||||
Europe |
173.3 | 123.2 | 40.7 | % | 20.0 | % | |||||||||||
Asia/Pacific Rim |
122.2 | 133.8 | (8.7 | %) | (16.0 | %) | |||||||||||
Total Retail Sales |
$ | 457.1 | $ | 432.7 | 5.6 | % | 0.0 | % | |||||||||
Retail sales in The Americas decreased $14.1 million or 8.0% for the three months ended March 31, 2003 as compared to the same period in 2002. In local currency, retail sales decreased by 1.0%. The decrease was mainly due to weaker local currencies in Mexico and South America as well as the adverse impact the Iraqi war and the harsh winter in the USA had on consumer sentiment and purchases.
Retail sales in Europe increased $50.1 million or 40.7 % for the three months ended March 31, 2003 as compared to the same period in 2002. In local currency, retail sales in Europe increased 20.0%. The increase was primarily due to a stronger Euro and a continuing positive sales momentum.
Retail sales in Asia/Pacific Rim decreased $11.6 million, or 8.7% for the three months ended March 31, 2003 as compared to the same period in 2002. In local currency, retail sales for Asia/Pacific Rim decreased 16.0%. The decline was due to deteriorating economic conditions and the intensified competitive sales environment. The outbreak of SARS in certain countries also had a negative impact on retail sales.
Retail Sales by Product Category
Quarter Ended March 31 | |||||||||||||
2003 | 2002 | % Change | |||||||||||
(Dollars in millions) | |||||||||||||
Nutritional Supplements |
$ | 206.7 | $ | 196.6 | 5.1 | % | |||||||
Weight Management Products |
200.7 | 184.9 | 8.5 | % | |||||||||
Personal Care Products |
43.9 | 45.4 | (3.3 | %) | |||||||||
Literature, Promotional and Other |
5.8 | 5.8 | | ||||||||||
Total |
$ | 457.1 | $ | 432.7 | 5.6 | % | |||||||
For the three months ended March 31, 2003, retail sales of the nutritional supplement and weight management product categories increased as compared to the prior year, primarily due to stronger euro and new products introduction. For the three months ended March 31, 2003, retail sales of personal care products decreased as compared to the prior year, primarily due to the discontinuation of certain body care and color cosmetic products.
Operating Information
Gross profit was $223.1 million for the three months ended March 31, 2003 compared to $208.7 million in the same period in 2002. As a percentage of net sales, gross profit for the three months ended March 31, 2003 increased from 78.5% to 79.7% as compared to the same period in 2002. The increase in gross profit reflected a reduction in the inventory provision for slow moving and obsolescence when comparing 2003 to 2002 and lower freight expenses.
Royalty overrides as a percentage of net sales were 35.5% for the three months ended March 31, 2003 as compared to 35.6% in the same period in 2002. The ratio varies slightly from period to period primarily due to a change in the mix of products and countries because full royalty overrides are not paid on certain products or in certain countries.
14
Marketing, distribution and administrative expenses as a percentage of net sales were 30.1% for the three months ended March 31, 2003, as compared to 30.5% in the same period in 2002. For the three months ended March 31, 2003, these expenses increased $3.2 million to $84.3 million from $81.1 million in the same period in 2002. The increase was primarily due to $0.9 million of intangible assets amortization in the first quarter of 2003, $1.3 million of monitoring fees and $1.6 million of other expenses under the monitoring fee agreements (discussed in Note 3) in the first quarter of 2003, and $1.5 million higher of foreign exchange losses when comparing 2003 to 2002. The increase was partially offset by a $2.1 million reduction in other operating expenses as a result of cost savings initiatives.
Net interest expense was $8.3 million for the three months ended March 31, 2003 as compared to net interest income of $0.5 million in the same period in 2002. In 2003, the interest expense was mainly related to the term loan and the senior subordinated notes issued to finance the merger transactions.
Income taxes were $12.4 million for the three months ended March 31, 2003, as compared to $13.4 million for the same period in 2002. As a percentage of pre-tax income, the estimated annual effective income tax rate was 40% for both 2003 and 2002.
Currency fluctuations had a favorable effect of $2.6 million on net income for the three months ended March 31, 2003 when recalculating current year net income using last years foreign exchange rates. For the three months ended March 31, 2003, the regional effects were $1.9 million unfavorable in The Americas, $1.6 million favorable in the Asia/Pacific Rim, and $2.9 million favorable in Europe.
Net income for the three months ended March 31, 2003 was $18.6 million compared to net income of $19.9 million for the same period in 2002. The decrease is mainly due to higher interest expense related to the term loan and the senior subordinated notes issued to finance the merger transactions.
Liquidity and Capital Resources
The Company has historically met its working capital and capital expenditure requirements, including funding for expansion of operations, through net cash flows provided by operating activities. The Companys principal source of liquidity is its operating cash flows. A substantial decrease in sales of the Companys products would reduce the availability of funds.
For the three months ended March 31, 2003, net cash used in operating activities was $2.0 million comprised of net income of $18.6 million, non-cash adjustments to net income of $9.5 million, and changes in operating assets and liabilities of $30.1 million. The change in operating assets and liabilities was mainly to pay $17 million of President Team Bonus and $13 million of interest expense.
Capital expenditures including capital leases for the three months ended March 31, 2003 were $2.7 million compared to $3.7 million in the same period in 2002. The majority of these expenditures represented investments in management information systems, office facilities and equipment in the United States.
As of March 31, 2003, the Company had working capital of $23.6 million. Cash, cash equivalents and marketable securities were $71.4 million at March 31, 2003. In view of the Company cash, the addition of liquidity from future operating cash flows and a $25 million working capital facility, we expect the Company to meet its working capital requirements for the foreseeable future.
In connection with the merger, the Parent and its affiliates consummated certain related financing transactions, including issuing senior subordinated notes in the amount of $165 million, and the entering into of the Senior Credit Facility, consisting of a term loan in the original principal amount of $180 million and a revolving credit facility in the amount of $25 million.
Historically, the Company had not been subjected to material price increases by its suppliers. In 2001, the Companys implementation of multiple source suppliers resulted in price decreases. The Company believes that in the event of price increases, it has the ability to respond to a portion of any price increases by raising the price of its products. The majority of the Companys purchases from its suppliers generally are made in U.S. dollars, while sales to its distributors generally are made in local currencies. Consequently, strengthening of the U.S. dollar versus a foreign currency can have a negative impact on operating margins and can generate transaction losses on intercompany transactions. For discussion of the Companys foreign exchange contracts and other hedging arrangements, see Item 3 of this report.
For a discussion of certain contingencies that may impact liquidity and capital resources, see Note 5, in the Notes to Consolidated Financial Statements included herein.
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS
The Company is exposed to market risks, which arise during the normal course of business from changes in interest rates and foreign currency exchange rates. On a selected basis, the Company uses derivative financial instruments to manage or hedge these risks. All
15
hedging transactions are authorized and executed pursuant to written guidelines and procedures. A discussion of the Companys primary market risk exposures and derivatives is presented below. Also, see Note 8, Derivative Instruments and Hedging Activities in the Companys consolidated financial statements included herein.
Foreign Exchange Risk
The Company enters into foreign exchange derivatives in the ordinary course of business primarily to reduce exposure to currency fluctuations attributable to intercompany transactions and translation of local currency revenue. Most of these foreign exchange contracts are designated for forecasted transactions.
The Company purchases average rate put options, which give the Company the right, but not the obligation, to sell foreign currency at a specified exchange rate (strike rate). These contracts provide protection in the event the foreign currency weakens beyond the option strike rate. In some instances, the Company sells (writes) foreign currency call options to finance the purchase of put options, which gives the counterparty the right, but not the obligation, to buy foreign currency from the Company at a specified strike rate. These contracts serve to limit the benefit the Company would otherwise derive from strengthening of the foreign currency beyond the strike rate. Such written call options are only entered into contemporaneously with purchased put options. The fair value of option contracts is based on third-party bank quotes.
The following table provides information about the details of our option contracts at March 31, 2003.
Average | Fair | Maturity | ||||||||||||||
Foreign Currency | Coverage | Strike Price | Value | Date | ||||||||||||
Purchased Puts (Company may sell Yen/Buy USD) |
||||||||||||||||
Japanese Yen |
$ | 9,000,000 | 117.02 119.30 | $ | 107,000 | Apr - Jun 2003 | ||||||||||
Japanese Yen |
1,000,000 | 116.87 | 24,000 | Jul - Sep 2003 | ||||||||||||
$ | 10,000,000 | $ | 131,000 | |||||||||||||
Purchased Puts (Company may sell Euro/Buy USD) |
||||||||||||||||
Euro |
$ | 15,000,000 | 1.00 1.03 | $ | 12,000 | Apr Jun 2003 | ||||||||||
Written Puts (Company may buy Euro/Sell USD) |
||||||||||||||||
Euro |
$ | (6,000,000 | ) | 1.00 1.01 | $ | (2,000 | ) | Apr Jun 2003 |
Foreign exchange forward contracts are occasionally used to hedge advances between subsidiaries and bank loans denominated in currencies other than their local currency. The objective of these contracts is to neutralize the impact of foreign currency movements on the subsidiarys operating results. The fair value of forward contracts is based on third-party bank quotes.
The table below describes the forward contracts that were outstanding at March 31, 2003.
Contract | Forward | Maturity | Contract | Fair | ||||||||||||||||
Foreign Currency | Date | Position | Date | Rate | Value | |||||||||||||||
Buy US Dollar/Sell Mexican Peso |
03/03/03 | $ | 3,200,000 | 04/07/03 | 10.68-11.17 | $ | 3,053,000 | |||||||||||||
Buy US Dollar/Sell Brazilian Real |
03/17/03 | 1,000,000 | 04/16/03 | 3.74 | 954,000 | |||||||||||||||
Buy Euro/Sell British Pound |
03/06/03 | 325,000 | 04/07/03 | 1.46 | 327,000 | |||||||||||||||
Buy Danish Kroner/Sell British Pound |
03/06/03 | 379,000 | 04/07/03 | 10.83 | 382,000 | |||||||||||||||
Buy Norway Kroner/Sell British Pound |
03/06/03 | 262,000 | 04/07/03 | 11.45 | 261,000 |
All foreign subsidiaries, excluding those operating in hyper-inflationary environments, designate their local currencies as their functional currency. At March 31, 2003, the total amount of foreign subsidiary cash was $60.3 million, of which $3.4 million was invested in U.S. dollars. At March 31, 2003 the cash balances in Japan and South Korea were $11.3 million and $7.2 million, respectively.
Interest Rate Risk
The Company maintains an investment portfolio of high-quality marketable securities. According to the Companys investment policy, the Company may invest in taxable and tax exempt instruments including asset-backed securities. In addition, the policy establishes limits on credit quality, maturity, issuer and type of instrument. The Company does not use derivative instruments to hedge its investment portfolio.
The Companys cash equivalents and short-term investments at March 31, 2003 of $1.3 million were invested in high-quality marketable securities.
The table below presents principal cash flows and interest rates by maturity dates and the fair values of the Companys borrowings as of March 31, 2003. Fair values for fixed rate borrowings have been determined based on recent market trade values. The fair values for
16
variable rate borrowings approximate their carrying value. Variable interest rates disclosed represent the rates on the borrowings at March 31, 2003. Interest rate risk related to the Companys capital leases is not significant.
Expected Maturity Date | |||||||||||||||||||||||||||||||||
2003 | 2004 | 2005 | 2006 | 2007 | Thereafter | Total | Fair Value | ||||||||||||||||||||||||||
Long-term Debt |
|||||||||||||||||||||||||||||||||
Fixed Rate |
| | | | | 163,059,000 | 163,059,000 | 179,025,000 | |||||||||||||||||||||||||
Average Interest Rate |
12.00 | % | |||||||||||||||||||||||||||||||
Variable Rate |
15,242,000 | 26,129,000 | 26,129,000 | 26,129,000 | 26,129,000 | 15,242,000 | 135,000,000 | 146,475,000 | |||||||||||||||||||||||||
Average Interest Rate |
5.34 | % | 5.34 | % | 5.34 | % | 5.34 | % | 5.34 | % | 5.34 | % |
Interest rate caps are used to hedge the interest rate exposure on the term loan which has a variable interest rate. They provide protection in the event the LIBOR rates increases beyond the cap rate. The table below describes the interest rate cap that was outstanding at March 31, 2003.
Interest Rate | Notional Amount | Cap Rate | Fair Value | Maturity Date | ||||||||||||
At
March 31, 2003 Interest Rate Cap |
$ | 40,000,000 | 5 | % | $ | 92,000 | October 2005 |
Item 4. CONTROLS AND PROCEDURES
(a) Evaluation of disclosure controls and procedures. Based on their evaluation as of a date within 90 days of the filing date of this Quarterly Report on Form 10-Q, the Companys principal executive officers and principal financial officer have concluded that the Companys disclosure controls and procedures (as defined in Rules 13a-14(c) and 15d-14(c) under the Securities Exchange Act of 1934 (the Exchange Act)) are effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.
(b) Changes in internal controls. There were no significant changes in the Companys internal controls or in other factors that could significantly affect these controls subsequent to the date of their evaluation. There were no significant deficiencies or material weaknesses, and therefore there were no corrective actions taken.
PART II. OTHER INFORMATION
Item 1. LEGAL PROCEEDINGS
See discussion under Note 5 to the Notes to the Consolidated Financial Statements included in Item 1 of this report.
Item 2. CHANGES IN SECURITIES AND USE OF PROCEEDS
None.
Item 3. DEFAULTS UPON SENIOR SECURITIES
None.
Item 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
None.
Item 5. OTHER INFORMATION
None.
17
Item 6. (a) EXHIBIT INDEX
Exhibit | ||||||
Number | Description | Page No./(Footnote) | ||||
2.1 | Agreement and Plan of Merger, dated April 10, 2002, by and among Herbalife International, Inc., WH Holdings (Cayman Islands) Ltd. and WH Acquisition Corp. | (11 | ) | |||
3.1 | Memorandum and Articles of Association of WH Intermediate Holdings Ltd. | (14 | ) | |||
4.1 | Indenture, dated as of June 27, 2002 between WH Acquisition Corp., WH Intermediate Holdings Ltd., WH Luxembourg Holdings SàRL, WH Luxembourg Intermediate Holdings SàRL, WH Luxembourg CM SàRL and The Bank of New York as Trustee governing 11 3/4% Senior Subordinated Notes due 2010 | (12 | ) | |||
10.1 | The Companys 1991 Stock Option Plan, as amended | (4 | ) | |||
10.2 | The Companys 1992 Executive Incentive Compensation Plan, as amended * | (1), | (4) | |||
10.3 | Form of Individual Participation Agreement relating to the Companys Executive Compensation Plan * | (1 | ) | |||
10.4 | Form of Indemnity Agreement between the Company and certain officers and directors of the Company * | (1 | ) | |||
10.5 | 1994 Performance Based Annual Incentive Compensation Plan, as amended and restated in 1996 * | (2),(4),(5) | ||||
10.6 | Office lease agreement between the Company and State Teachers Retirement System, dated July 20, 1995 | (3 | ) | |||
10.7 | The Companys Senior Executive Deferred Compensation Plan, effective January 1, 1996, as amended * | (3 | ) | |||
10.8 | The Companys Management Deferred Compensation Plan, effective January 1, 1996, as amended * | (3 | ) | |||
10.9 | Master Trust Agreement between the Company and Imperial Trust Company, Inc., effective January 1, 1996 * | (3 | ) | |||
10.10 | The Companys 401K Plan, as amended * | (3 | ) | |||
10.11 | The Companys Supplemental Executive Retirement Plan * | (6 | ) | |||
10.12 | Credit Agreement between Herbalife International of America, Inc. and First National Bank of Chicago, dated December 14, 1998 | (7 | ) | |||
10.13 | Employment agreement, dated as of November 1, 2000, between John Reynolds and Herbalife International, Inc. and Herbalife International of America, Inc. * | (8 | ) | |||
10.14 | Employment agreement, dated as of August 20, 2000, between Carol Hannah and Herbalife International, Inc. and Herbalife International of America, Inc. * | (8 | ) | |||
10.15 | Employment agreement, dated as of August 20, 2000 between Brian Kane and Herbalife International, Inc. and Herbalife International of America, Inc. * | (8 | ) | |||
10.16 | The Companys Management Employee Change in Control Plan, effective June 29, 2000 * | (8 | ) | |||
10.17 | Trust Agreement for Herbalife 2001 Executive Retention Plan, effective March 15, 2001 * | (9 | ) | |||
10.18 | The Companys 2001 Executive Retention Plan, effective March 15, 2001 | (9 | ) | |||
10.19 | Employment agreement, dated as of August 20, 2000 between Frank Morse and Herbalife International, Inc. and Herbalife International of America, Inc. * | (10 | ) | |||
10.20 | Employment agreement, dated as of November 1, 2001 between Francis X. Tirelli and Herbalife International, Inc. and Herbalife International of America, Inc. * | (10 | ) | |||
10.21 | Separation Agreement and General Release, dated December 31, 2001, between Timothy Gerrity and Herbalife International, Inc. and Herbalife International of America, Inc. *# | (10 | ) | |||
10.22 | Separation Agreement and General Release, dated October 19, 2001, between Christopher Pair and Herbalife International, Inc. and Herbalife International of America, Inc. *# | (10 | ) |
18
Exhibit | ||||||
Number | Description | Page No./(Footnote) | ||||
10.23 | Separation Agreement and General Release, dated as of May 17, 2002, between Robert Sandler and Herbalife International, Inc. and Herbalife International of America, Inc. and Clarification Re Paragraph 3(a) Of Separation and General Release Agreement*# | (12 | ) | |||
10.24 | Agreement for retention of legal services, dated as of May 20, 2002, by and among Herbalife International, Inc., Herbalife International of America, Inc. and Robert Sandler* | (12 | ) | |||
10.25 | Purchase Agreement, dated as of June 21, 2002, by and among WH Acquisition Corp., Herbalife International, Inc., WH Intermediate Holdings Ltd., WH Luxembourg Holdings SàRL, WH Luxembourg Intermediate Holdings SàRL, WH Luxembourg CM SàRL and UBS Warburg LLC | (12 | ) | |||
10.26 | Registration Rights Agreement, dated as of June 27, 2002, by and among WH Acquisition Corp., WH Intermediate Holdings Ltd., WH Luxembourg Holdings SàRL, WH Luxembourg Intermediate Holdings SàRL, WH Luxembourg CM SàRL and UBS Warburg LLC | (12 | ) | |||
10.27 | Credit Agreement, dated as of July 31, 2002, by and among Herbalife International, Inc., WH Holdings (Cayman Islands) Ltd., WH Intermediate Holdings Ltd., WH Luxembourg Holdings SàRL, WH Luxembourg Intermediate Holdings SàRL, WH Luxembourg CM SàRL and the Subsidiary Guarantors party thereto, and certain lenders and agents named therein | (12 | ) | |||
10.28 | Security Agreement, dated as of July 31, 2002, by Herbalife International, Inc., WH Holdings (Cayman Islands) Ltd., WH Intermediate Holdings Ltd., WH Luxembourg Holdings SàRL, WH Luxembourg Intermediate Holdings SàRL, WH Luxembourg CM SàRL and the Subsidiary Guarantors party thereto in favor of UBS AG, Stamford Branch, as Collateral Agent | (12 | ) | |||
10.29 | Amendment to Agreements of Distributorship, effective as of July 31, 2002 made and entered into by Herbalife International, Inc. for the benefit of all of Herbalife International, Inc.s existing and future independent distributors that meet the requirements to become (or remain) a distributor according to company policy | (12 | ) | |||
10.30 | Monitoring Fee Agreement dated as of July 31, 2002, between Herbalife International, Inc. and Whitney & Co., LLC | (14 | ) | |||
10.31 | Monitoring Fee Agreement dated as of July 31, 2002, between Herbalife International, Inc. and GGC Administration, LLC | (14 | ) | |||
10.32 | Indemnity Agreement dated as of July 31, 2002, by and among WH Holdings (Cayman Islands) Ltd., Whitney Strategic Partners V, L.P., GGC Administration, L.L.C., Golden Gate Private Equity, Inc., CCG Investments (BVI), L.P., Series C, CCG AV, LLC-Series E, CCG Associates-QP, LLC and WH Investments Ltd. | (14 | ) | |||
10.33 | Independent Directors Stock Option Plan of WH Holdings (Cayman Islands) | (14 | ) | |||
10.34 | Executive Officer Stock Option Plan of WH Holdings (Cayman Islands) Ltd. | (14 | ) | |||
10.35 | Amendment No. 1 to Credit Agreement dated as of December 18, 2002, among Herbalife International, Inc., WH Holdings (Cayman Islands) Ltd., WH Intermediate Holdings Ltd., WH Luxembourg Holdings SàRL, WH Luxembourg Intermediate Holdings SàRL, WH Luxembourg CM SàRL and each of the Subsidiary Guarantors | (14 | ) | |||
10.36 | Employment Agreement, dated as of March 10, 2003 between Brian Kane and Herbalife International, Inc. and Herbalife International of America, Inc. | (15 | ) | |||
10.37 | Employment Agreement dated as of March 10, 2003 between Carol Hannah and Herbalife International, Inc. and Herbalife International of America, Inc. | (15 | ) | |||
10.38 | Non-Statutory Stock Option Agreement, dated as of March 10, 2003 between WH Holdings (Cayman Islands) Ltd. and Brian Kane | (15 | ) | |||
10.39 | Non-Statutory Stock Option Agreement, dated as of March 10, 2003 between WH Holdings (Cayman Islands) Ltd. and Carol Hannah | (15 | ) | |||
10.40 | WH Holdings (Cayman Islands) Ltd. Stock Option Plan | (15 | ) |
19
Exhibit | ||||||
Number | Description | Page No./(Footnote) | ||||
10.41 | Side Letter Agreement dated as of March 10, 2003 by and among WH Holdings (Cayman Islands) Ltd., Institutional Shareholders, Brian Kane and Carol Hannah | (16 | ) | |||
10.42 | Employment Agreement dated as of April 3, 2003 between Michael O. Johnson and Herbalife International, Inc. and Herbalife International of America, Inc. | (16 | ) | |||
10.43 | Non-Statutory Stock Option Agreement, dated as of April 3, 2003 between WH Holdings (Cayman Islands) Ltd. and Michael O. Johnson | (16 | ) | |||
10.44 | Side Letter Agreement dated as of April 3, 2003 by and among WH Holdings (Cayman Islands) Ltd., Institutional Shareholders and Michael O. Johnson | (16 | ) |
(1) | Incorporated by reference to the Companys Registration Statement on Form S-1 (No. 33-66576) declared effective by the Securities and Exchange Commission on October 8, 1993. | |
(2) | Incorporated by reference to the Companys Definitive Proxy Statement relating to its 1994 Annual Meeting of Stockholders. | |
(3) | Incorporated by reference to the Companys Annual Report on Form 10-K for the year ended December 31, 1995. | |
(4) | Incorporated by reference to the Companys Definitive Proxy Statement relating to its 1996 Annual Meeting of Stockholders. | |
(5) | Incorporated by reference to the Companys Definitive Proxy Statement relating to the Special Shareholder Meeting held on December 11, 1997. | |
(6) | Incorporated by reference to the Companys Annual Report on Form 10-K for the year ended December 31, 1997. | |
(7) | Incorporated by reference to the Companys Annual Report on Form 10-K for the year ended December 31, 1998. | |
(8) | Incorporated by reference to the Companys Quarterly Report on Form 10-Q for the three months ended September 30, 2000. | |
(9) | Incorporated by reference to the Companys Quarterly Report on Form 10-Q for the three months ended March 31, 2001. | |
(10) | Incorporated by reference to the Companys Annual Report on Form 10-K for the year ended December 31, 2001. | |
(11) | Incorporated by reference to the Companys Current Report on Form 8-K, dated April 10, 2002. | |
(12) | Incorporated by reference to the Companys Quarterly Report on Form 10Q for the three months ended June 30, 2002. | |
(13) | Incorporated by reference to the Companys Quarterly Report on Form 10Q for the three months ended September 30, 2002. | |
(14) | Incorporated by reference to Herbalife International, Inc.s Registration Statement on Form S-4 (No. 333-101188) declared effective by the Securities and Exchange Commission on December 24, 2002. | |
(15) | Incorporated by reference to the Companys Annual Report on Form 10K for the year ended December 31, 2002. | |
(16) | Filed herewith. | |
* | Management contract or compensatory plan or arrangement filed in response to Item 14(a)(3) of the instructions to Form 10-K. | |
# | Certain portions of this exhibit have been omitted and filed separately under an application for confidential treatment. |
20
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: May 9, 2003
WH INTERMEDIATE HOLDINGS LTD.
(Registrant)
By: | /s/ WILLIAM D. LOWE |
William D. Lowe Senior Vice President & Principal Financial and Accounting Officer |
CERTIFICATION
I, Michael O. Johnson, certify that:
1. | I have reviewed this quarterly report on Form 10-Q of WH Intermediate Holdings Ltd.; | |
2. | Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; | |
3. | Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; | |
4. | The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have: |
a) | designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; | ||
b) | evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the Evaluation Date); and | ||
c) | presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date; |
5. | The registrants other certifying officers and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent function): |
a) | all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and | ||
b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and |
6. | The registrants other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses. |
Date: May 9, 2003 | ||
/s/ MICHAEL O. JOHNSON
Michael O. Johnson Chief Executive Officer |
21
CERTIFICATION
I, Brian L. Kane, certify that:
7. | I have reviewed this quarterly report on Form 10-Q of WH Intermediate Holdings Ltd.; | |
8. | Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; | |
9. | Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; | |
10. | The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have: |
a) | designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; | ||
b) | evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the Evaluation Date); and | ||
c) | presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date; |
11. | The registrants other certifying officers and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent function): |
a) | all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and | ||
b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and |
12. | The registrants other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses. |
Date: May 9, 2003 | ||
/s/ BRIAN L. KANE
Brian L. Kane Co-President |
CERTIFICATION
I, Carol Hannah, certify that:
1. | I have reviewed this quarterly report on Form 10-Q of WH Intermediate Holdings Ltd.; | |
2. | Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; | |
3. | Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; | |
4. | The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have: |
a) | designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; | ||
b) | evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the Evaluation Date); and | ||
c) | presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date; |
5. | The registrants other certifying officers and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent function): |
22
a) | all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and | ||
b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and |
6. | The registrants other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses. |
Date: May 9, 2003 | ||
/s/ CAROL HANNAH Carol Hannah Co-President |
CERTIFICATION
I, William D. Lowe, certify that:
1. | I have reviewed this quarterly report on Form 10-Q of WH Intermediate Holdings Ltd.; | |
2. | Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; | |
3. | Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; | |
4. | The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have: |
a) | designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; | ||
b) | evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the Evaluation Date); and | ||
c) | presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date; |
5. | The registrants other certifying officers and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent function): |
a) | all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and | ||
b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and |
6. | The registrants other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses. |
Date: May 9, 2003 | ||
/s/ WILLIAM D. LOWE
William D. Lowe Senior Vice President and Principal Financial and Accounting Officer |
23